Business
Press Release May 30 2023
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 30, 2023, titled \"Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis\". View Attachment","length":414,"tagName":"div"}]